FRANKLIN, Tenn., June 24, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, is set to be added as a member of the broad-market Russell 3000® Index,
FRANKLIN, Tenn., May 25, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover” or “Clover Health”), a physician enablement company committed to improving health equity for seniors, today announced the appointment of Scott J. Leffler as Chief Financial Officer (“CFO”).
First quarter total revenue was $874.4 million, compared to $200.3 million in first quarter 2021 Lives under Clover Management grew to ~257,000 from ~66,000 year-over-year First quarter Insurance (Medicare Advantage) Medical Care Ratio (MCR) of 96.4% and Non-Insurance (Direct Contracting) MCR of
FRANKLIN, Tenn., May 09, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover” or “Clover Health”), a physician enablement company committed to improving health equity for seniors, today announced the appointment of Aric Sharp as Chief Executive Officer (“CEO”) of Value
FRANKLIN, Tenn., April 27, 2022 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Vivek Garipalli, will present at the Bank of America 2022 Healthcare Conference on Wednesday, May 11,
FRANKLIN, Tenn., April 11, 2022 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that it will report first quarter 2022 financial results after market close on Monday, May
FRANKLIN, Tenn., March 15, 2022 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that on March 14, 2022, the Talent and Compensation Committee of the Company’s Board of
NASHVILLE, Tenn., March 14, 2022 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ: CLOV) (“Clover”), a physician enablement company committed to improving health equity for seniors, today announced the appointment of Joseph Martin as General Counsel, effective March 14, 2022.
FRANKLIN, Tenn., March 08, 2022 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV), a physician enablement company focused on improving health outcomes for America's seniors, today announced that its CEO, Vivek Garipalli, will present at Barclays 2022 Global Healthcare Conference on Tuesday, March
NASHVILLE, Tenn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ: CLOV) (“Clover”), a technology company committed to improving health equity for seniors, today announced the appointment of Conrad Wai as Chief Technology Officer (“CTO”) to drive development and growth of Clover’s flagship
